Switzerland has increased its coronavirus vaccine order with Moderna by three million doses. This Alpine country now has 15.8 million doses of vaccines on order from three different manufacturers, pending approval from the health regulator.
This content was published on
2 minutes
swissinfo.ch/mga
The Swiss government increased its previous order with the US biotechnology company for its mRNA vaccine to a new total of 7.5 million doses, it was announced on Tuesday. Earlier this week, Switzerland added a vaccine from Pfizer/BioNTech to its desired stockpile list.
Switzerland’s membership of the World Health Organization COVAXExternal link initiative would also grant access to enough vaccines to cover 20% of the Swiss population.
Health regulator Swissmedic is currently evaluating the safety of several vaccine candidates under its “rolling procedure”, which allows manufacturers to submit the results of test studies in stages. So far, no vaccine has yet been approved.
On Wednesday, Swiss pharmaceutical giant Roche said it had reached an agreement with Moderna to extend the use of its Elecsys Anti-SARS-CoV-2 Sdiagnostic tool to speed up testing of its vaccine.
“To enhance our understanding of vaccines against SARS-CoV-2 there would be a benefit in knowing the starting levels of antibodies a person has, prior to vaccination, in order to evaluate any change in antibody levels that the vaccine induces,” Roche stated in a press release.
The Elecsys Anti-SARS-CoV-2 Sdiagnostic tool was granted emergency use authorisation by the US health authorities last month.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
Watches belonging to Michael Schumacher up for auction
This content was published on
Schumacher's family is auctioning off eight rare watches from his collection in Geneva. The Christie's auction will take place on Monday.
Joya Marleen and Baschi named best solo acts at Swiss Music Awards
This content was published on
St. Gallen singer Joya Marleen and Baschi from Basel were named artists of the year at the Swiss Music Awards 2024 on Wednesday night.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Incomplete data stalls Swiss authorisation of Covid-19 vaccines
This content was published on
Switzerland’s medical regulator says it lacks the necessary information to sign off on three different vaccines ordered by the government.
Switzerland secures three million doses of Pfizer/BioNTech vaccine
This content was published on
Some 4.5 million doses of another vaccine have already been agreed with United States pharma company Moderna and another 5.3 million doses from the British-Swedish firm AstraZeneca. The government said on MondayExternal link that membership of the World Health Organization COVAXExternal link initiative grants vaccine coverage to 20% of the Swiss population. The Pfizer/BioNTech vaccine would require…
This content was published on
With a death toll of over 5,000, Switzerland (population 8.5 million) expects to launch its coronavirus vaccination campaign in early January.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.